2011
DOI: 10.1089/scd.2010.0082
|View full text |Cite
|
Sign up to set email alerts
|

Deleterious Effects of Freezing on Osteogenic Differentiation of Human Adipose-Derived Stromal Cells In Vitro and In Vivo

Abstract: Human adipose-derived stromal cells (hASCs) represent a multipotent stromal cell type with a proven capacity to undergo osteogenic differentiation. Many hurdles exist, however, between current knowledge of hASC osteogenesis and their potential future use in skeletal tissue regeneration. The impact of frozen storage on hASC osteogenic differentiation, for example, has not been studied in detail. To examine the effects of frozen storage, hASCs were harvested from lipoaspirate and either maintained in standard cu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
50
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1
1

Relationship

5
5

Authors

Journals

citations
Cited by 56 publications
(54 citation statements)
references
References 56 publications
(89 reference statements)
4
50
0
Order By: Relevance
“…Osteogenic differentiation of cells followed a previously published protocol. 26,27 The medium was supplemented with 300-600 ng/mL of NELL-1, as previously described. 28 Osteogenic differentiation was assessed using alkaline phosphatase (ALP) and alizarin red (AR) staining at 5 and 10 days of osteogenic differentiation, respectively (with or without 300 ng/mL NELL-1).…”
Section: Cell Culturementioning
confidence: 99%
“…Osteogenic differentiation of cells followed a previously published protocol. 26,27 The medium was supplemented with 300-600 ng/mL of NELL-1, as previously described. 28 Osteogenic differentiation was assessed using alkaline phosphatase (ALP) and alizarin red (AR) staining at 5 and 10 days of osteogenic differentiation, respectively (with or without 300 ng/mL NELL-1).…”
Section: Cell Culturementioning
confidence: 99%
“…Proliferation was assessed by bromodeoxyuridine (BrdU) incorporation assays as previously described [34], exposed to recombinant human (rh) SHH-N (250 and 500 ng/mL; R&D Systems) and rhNELL-1 (100 and 300 ng/mL). Dosages were used based on previous publications [12,33].…”
Section: Bromodeoxyuridine Incorporationmentioning
confidence: 99%
“…Scaffolds are custom-made per previously published protocol from poly(lactic-co-glycolic acid) (PLGA, Burmingham Polymer) with hydroxyapatite coating [4][5][6] . Apatite-coated PLGA scaffolds are fabricated from 85/15 PLGA by solvent casting and a particulate leaching process.…”
Section: Scaffold Creationmentioning
confidence: 99%